Emergent Biosolutions EBS Other — Long-Lived Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Emergent Biosolutions’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's other — long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's other — long-lived assets?
- Emergent Biosolutions (EBS) reported other — long-lived assets of $2.5M in Q4 2025.
- How has Emergent Biosolutions's other — long-lived assets changed year-over-year?
- Emergent Biosolutions's other — long-lived assets decreased by 7.4% year-over-year, from $2.7M to $2.5M.
- What does other — long-lived assets mean?
- Measures the total book value of non-current, tangible, and intangible assets allocated to the 'Other' business segment. This metric reflects the capital intensity and infrastructure investment dedicated to these secondary operations. Tracking these assets provides insight into the company's long-term commitment to these business areas and the potential for future capacity or operational scaling.